Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning

Keyphrases

• Absolute Lymphocyte Count 25%
• Acute Leukemia 25%
• Acute Relapse 25%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 25%
• Clinical Data 25%
• Confidence Interval 50%
• Fludarabine 100%
• Graft-versus-host Disease (GvHD) 50%
• Hematopoietic SCT 100%
• Lymphocytes 100%
• Melphalan 50%
• Melphalan Conditioning 100%
• Monocyte Count 25%
• Monocytes 100%
• Multivariate Analysis 25%
• Myeloablative 25%
• P300 25%
• Patient Clustering 50%
• Peripheral Blood 25%
• Poor Outcome 25%
• Prognostic Value 25%
• Reduced Intensity 25%
• Risk Ratio 50%
• Severe Acute 25%
• Unsupervised Hierarchical Clustering 25%

Medicine and Dentistry

• Acute Leukemia 20%
• Conditioning 100%
• Fludarabine 100%
• Graft Versus Host Reaction 40%
• Lymphocyte 100%
• Melphalan 100%
• Multivariate Analysis 20%

Immunology and Microbiology

• Conditioning 100%
• Graft-Versus-Host Disease 50%
• Lymphocyte 100%
• Lymphocyte Count 25%
• Monocyte Count 25%